Impact of Prophylactic Octreotide to Pancreatic Exocrine Secretion

NCT02920567 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

282

Enrollment

OTHER

Sponsor class

Conditions

Periampullary Tumors

Interventions

DRUG: Octreotide
DRUG: Placebo

Sponsor

Saint Vincent's Hospital, Korea